Rapha Capital Management, LLC (https://www.raphacap.com), an investment management firm located in Miami, Florida, through Rapha Capital Investment IX, LLC ("RCI IX") (an entity managed by Rapha Capital), led FIZE Medical Inc.'s ("FIZE")(www.fizemedical.com) recently closed Series A financing.  RCI IX was joined by MIG FZ LLC, incorporated by a group of pharmaceutical and biotechnology executives and investors, led by Michael Ingber MD, Director of The Center for Specialized Women's Health at Garden State Urology, within Atlantic Health System.  The $2 million financing will be used to further develop and launch FIZE's novel device, the first accurate, automatic, digital, and cost-effective device to measure urine output in real time, replacing the current, manually managed, urinometer bag attached to a standard Foley catheter, to be made available to hospitals and physicians worldwide.  With the close of Series A, Kevin Slawin, founder and managing partner of Rapha Capital Management, joined the board of FIZE, and Michael Ingber, MD, joined as a board observer.